HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yuan Yang Selected Research

protein O-mannose beta-1,2-N-acetylglucosaminyltransferase

4/2013Biochemical and biophysical changes underlie the mechanisms of basement membrane disruptions in a mouse model of dystroglycanopathy.
12/2007Ectopia of meningeal fibroblasts and reactive gliosis in the cerebral cortex of the mouse model of muscle-eye-brain disease.
5/2007Breaches of the pial basement membrane and disappearance of the glia limitans during development underlie the cortical lamination defect in the mouse model of muscle-eye-brain disease.
3/2007Breaches of the pial basement membrane and disappearance of the glia limitans during development underlie the cortical lamination defect in the mouse model of muscle-eye-brain disease.
3/2006A genetic model for muscle-eye-brain disease in mice lacking protein O-mannose 1,2-N-acetylglucosaminyltransferase (POMGnT1).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yuan Yang Research Topics

Disease

127Neoplasms (Cancer)
08/2022 - 08/2005
67Hepatocellular Carcinoma (Hepatoma)
06/2022 - 08/2008
27Neoplasm Metastasis (Metastasis)
06/2022 - 01/2011
26Inflammation (Inflammations)
12/2022 - 01/2002
26Infections
03/2022 - 09/2006
17Breast Neoplasms (Breast Cancer)
06/2022 - 01/2012
13Carcinogenesis
10/2021 - 10/2006
12Liver Neoplasms (Liver Cancer)
12/2021 - 01/2013
11Hepatitis B
01/2022 - 08/2013
11Fibrosis (Cirrhosis)
12/2020 - 05/2007
10Hypoxia (Hypoxemia)
12/2021 - 01/2011
10Glioma (Gliomas)
07/2018 - 01/2014
8Atherosclerosis
03/2022 - 08/2004
8Colorectal Neoplasms (Colorectal Cancer)
11/2021 - 09/2014
8Proteinuria
01/2021 - 12/2013
8Parkinson Disease (Parkinson's Disease)
01/2021 - 01/2012
7COVID-19
11/2022 - 09/2020
7Type 2 Diabetes Mellitus (MODY)
01/2020 - 05/2013
7Hemorrhage
08/2019 - 05/2007
6Rheumatoid Arthritis
12/2022 - 10/2004
6Diabetes Mellitus
06/2022 - 02/2014
6Ischemic Stroke
02/2022 - 10/2016
6Stroke (Strokes)
02/2022 - 10/2016
6Asthma (Bronchial Asthma)
02/2022 - 12/2010
6Chronic Hepatitis B
01/2022 - 10/2015
6Hypertension (High Blood Pressure)
08/2021 - 09/2015
6Azoospermia
07/2010 - 01/2007
6Oligospermia (Oligozoospermia)
07/2010 - 01/2007
5Sleep Initiation and Maintenance Disorders (Insomnia)
01/2021 - 11/2019
5Pain (Aches)
01/2021 - 01/2017
5Thrombosis (Thrombus)
07/2019 - 02/2013
5Anemia
01/2019 - 07/2008
5Obesity
11/2018 - 09/2015
4Cholangiocarcinoma
08/2022 - 01/2019
4Myocardial Infarction
05/2022 - 08/2015
4Stomach Neoplasms (Stomach Cancer)
01/2022 - 01/2021
4Lung Neoplasms (Lung Cancer)
01/2022 - 01/2015
4Atrial Fibrillation
01/2022 - 04/2017
4Melanoma (Melanoma, Malignant)
11/2021 - 03/2014
4Diabetic Retinopathy (Retinopathy, Diabetic)
08/2021 - 03/2020
4Heart Failure
04/2021 - 05/2008
4Prostatic Neoplasms (Prostate Cancer)
02/2021 - 01/2012
4Diabetic Nephropathies (Diabetic Nephropathy)
01/2021 - 01/2016
4Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
01/2021 - 10/2011
4Lipoprotein Glomerulopathy
01/2021 - 02/2013
4Margins of Excision
01/2021 - 05/2013
4Liver Cirrhosis (Hepatic Cirrhosis)
07/2020 - 01/2019
4Nephrotic Syndrome (Syndrome, Nephrotic)
05/2019 - 02/2013

Drug/Important Bio-Agent (IBA)

39Biomarkers (Surrogate Marker)IBA
02/2022 - 01/2014
38Proteins (Proteins, Gene)FDA Link
02/2022 - 03/2006
21DNA (Deoxyribonucleic Acid)IBA
05/2022 - 02/2007
19Pharmaceutical PreparationsIBA
03/2022 - 08/2004
18MicroRNAs (MicroRNA)IBA
02/2022 - 07/2011
16Messenger RNA (mRNA)IBA
02/2022 - 06/2002
15Long Noncoding RNAIBA
01/2022 - 12/2012
14CytokinesIBA
01/2022 - 04/2014
13AntigensIBA
01/2022 - 08/2005
10Biological ProductsIBA
08/2022 - 01/2013
9LipidsIBA
11/2018 - 08/2008
8Insulin (Novolin)FDA Link
06/2022 - 12/2012
8Glucose (Dextrose)FDA LinkGeneric
02/2022 - 04/2015
8Hepatitis B Surface Antigens (HBsAg)FDA Link
01/2022 - 05/2007
8RNA (Ribonucleic Acid)IBA
01/2022 - 09/2006
8Triglycerides (Triacylglycerol)IBA
08/2021 - 02/2014
7Anti-Bacterial Agents (Antibiotics)IBA
03/2022 - 02/2013
7Hemoglobins (Hemoglobin)IBA
02/2022 - 07/2008
7Antiviral Agents (Antivirals)IBA
01/2022 - 05/2013
7EnzymesIBA
10/2020 - 05/2009
7Fetal Proteins (Fetoprotein)IBA
07/2020 - 12/2013
6VaccinesIBA
12/2022 - 01/2013
6Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2022 - 01/2011
6LuciferasesIBA
08/2022 - 08/2008
6LigandsIBA
05/2022 - 10/2014
6CholesterolIBA
09/2021 - 08/2008
6Therapeutic UsesIBA
01/2021 - 06/2013
6Indicators and Reagents (Reagents)IBA
01/2021 - 11/2013
6CreatinineIBA
11/2020 - 12/2013
6Transcription Factors (Transcription Factor)IBA
01/2020 - 05/2008
5Metformin (Glucophage)FDA LinkGeneric
06/2022 - 09/2015
5Uric Acid (Urate)IBA
08/2021 - 01/2017
5AntibodiesIBA
08/2021 - 01/2018
5CarbohydratesIBA
01/2021 - 01/2017
5Estrogen ReceptorsIBA
12/2020 - 01/2014
5Immunoglobulins (Immunoglobulin)IBA
01/2019 - 08/2005
5Codon (Codons)IBA
09/2016 - 07/2008
5protein O-mannose beta-1,2-N-acetylglucosaminyltransferaseIBA
04/2013 - 03/2006
4LipopolysaccharidesIBA
12/2022 - 01/2018
4oxidized low density lipoproteinIBA
03/2022 - 04/2015
4Interleukin-6 (Interleukin 6)IBA
01/2022 - 03/2013
4IronIBA
10/2021 - 08/2017
4Phenobarbital (Luminal)FDA Link
01/2021 - 09/2018
4ErbB Receptors (EGF Receptor)IBA
01/2021 - 12/2013
4Apolipoproteins E (ApoE)IBA
01/2021 - 04/2013
4Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2021 - 12/2013
4CollagenIBA
12/2020 - 04/2010

Therapy/Procedure

68Therapeutics
12/2022 - 08/2008
12Hepatectomy
01/2021 - 05/2008
11Drug Therapy (Chemotherapy)
03/2022 - 12/2010
9Immunotherapy
01/2021 - 01/2014
8Radiotherapy
04/2020 - 01/2017